Nicotine replacement therapy agent

0 marketed 2 in Phase 3

This page covers all Nicotine replacement therapy agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nicotinic acetylcholine receptors.

Targets

Nicotinic acetylcholine receptors

Phase 3 pipeline (2)